Research Article
Comparison between Clinical Utility of CXCL-8 and Clinical Practice Tumor Markers for Colorectal Cancer Diagnosis
Table 4
Relationship between the serum CXCL-8, CEA, and CA19-9 levels and the clinicopathological features of patients with colorectal cancer.
| Clinicopathological characteristics | No. subjects | CXCL-8 (pg/mL) | CEA (ng/mL) | CA19-9 (U/mL) |
| Location | | | | | Colon | 122 | 37.58 (27.36–55.68) | 3.90 (2.20–8.63) | 14.28 (7.98–27.09) | Rectum | 105 | 37.75 (29.12–62.14) | 3.00 (1.80–6.80) | 14.17 (8.48–23.74) | value | | 0.458 | 0.111 | 0.580 | TNM stage | | | | | I | 42 | 37.66 (28.56–56.82) | 2.60 (1.48–4.75) | 13.78 (7.62–23.59) | II | 83 | 36.27 (27.38–62.06) | 3.20 (2.00–8.60) | 13.36 (7.50–25.86) | III | 85 | 36.83 (28.12–56.98) | 3.70 (2.10–7.75) | 14.36 (9.40–24.45) | IV | 17 | 53.38 (35.24–71.14) | 8.40 (4.75–38.50) | 22.71 (12.11–109.40) | value | | 0.423 | <0.001 | 0.073 | T stage | | | | | T1 | 11 | 38.98 (33.83–67.80) | 1.50 (1.20–2.90) | 11.21 (1.33–19.96) | T2 | 34 | 35.96 (28.93–55.05) | 2.92 (1.80–5.78) | 14.30 (8.77–23.59) | T3 | 154 | 36.33 (27.38–55.38) | 3.60 (2.08–8.40) | 13.86 (7.98–25.87) | T4 | 28 | 41.61 (31.35–69.72) | 6.65 (2.35–20.68) | 20.12 (11.60–48.44) | value | | 0.416 | 0.001 | 0.077 | N stage | | | | | N0 | 123 | 36.27 (27.42–54.69) | 2.90 (1.80–5.70) | 13.65 (7.75–24.39) | N1 | 60 | 47.16 (31.39–78.31) | 3.90 (2.45–9.05) | 13.94 (9.27–24.70) | N2 | 44 | 35.95 (28.16–51.60) | 4.90 (2.00–11.65) | 17.12 (11.05–27.54) | value | | 0.062 | 0.016 | 0.260 | M stage | | | | | M0 | 206 | 36.33 (27.72–55.38) | 3.20 (1.90–6.20) | 13.91 (8.14–23.46) | M1 | 21 | 53.38 (37.52–65.47) | 8.40 (4.20–28.52) | 23.52 (12.72–77.58) | value | | 0.039 | <0.001 | 0.007 | Histological grade | | | | | High | 6 | 39.52 (32.71–66.49) | 3.25 (2.20-4.30) | 15.83 (8.62-22.43) | Moderate | 206 | 37.66 (27.92–57.85) | 3.40 (1.90-7.60) | 13.91 (8.00-25.04) | Low | 15 | 40.94 (35.28–55.24) | 4.70 (1.95-14.65) | 22.71 (14.34-36.18) | value | | 0.718 | 0.621 | 0.095 | Vascular invasion | | | | | Present | 41 | 38.15 (26.34–56.93) | 4.20 (2.20–8.70) | 16.60 (9.16–3.19) | Absent | 175 | 38.16 (28.69–64.66) | 3.35 (1.90–7.20) | 13.84 (7.87–23.49) | Unknown | 11 | 35.97 (32.71–37.63) | 4.15 (2.60–6.10) | 19.11 (13.96–25.04) | value | | 0.638 | 0.523 | 0.082 | Nerve invasion | | | | | Present | 66 | 39.42 (28.85–76.51) | 4.20 (2.60–14.40) | 15.00 (9.16–35.27) | Absent | 155 | 36.98 (27.63–53.46) | 3.00 (1.80–5.95) | 13.86 (7.83–22.76) | Unknown | 5 | 56.11 (37.52–81.40) | 3.00 (2.90–5.30) | 19.96 (8.40–22.71) | value | | 0.184 | 0.007 | 0.165 | Tumor size (cm) | | | | | <5 | 129 | 36.11 (27.72–53.54) | 2.90 (1.80–5.70) | 14.50 (8.14–23.46) | ≥5 | 98 | 42.80 (29.02–76.20) | 4.15 (2.40–9.40) | 13.84 (8.80–32.91) | value | | 0.034 | 0.009 | 0.294 |
|
|
Data are presented as the median with the interquartile range and are statistically significant at (bold). |